Medicine & Health

Heath Rutledge-Jukes, 25, a second-year student at WashU Medicine, has earned a spot on Forbes’ “30 Under 30” education list.

Neuroscientist Juliet Mwirigi, a postdoctoral researcher in the Department of Anesthesiology at WashU Medicine, has been named a Hanna H. Gray Fellow by the Howard Hughes Medical Institute.

WashU Olin Business School recently launched a new health initiative that envisions Olin as the premier institution for the business of health and an engine for innovation at WashU. 

WashU Medicine and the Weizmann Institute of Science have launched a collaboration to support joint research projects focused on understanding the role of microbes and the immune and nervous systems in human health and disease.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S.

Researchers at WashU Medicine have received two grants totaling more than $10 million from the National Institutes of Health (NIH) to study the human body’s resident viruses, those not known to be associated with disease.

Juliane Bubeck Wardenburg, MD, PhD, at WashU Medicine, brings empathy and compassion to families with children in critical care. She also is working on strategies to prevent staph infections in infants.

WashU Medicine researchers have received two large grants from the NIH renewing funding for the Human Pangenome Reference Sequencing Project.

Cory Berkland has been named the inaugural Mark and Becky Ruhmann Levin Professor in the McKelvey School of Engineering at Washington University.

People prescribed the popular GLP-1 weight-loss drugs such as Ozempic and Mounjaro may experience benefits such as increased cognitive and behavioral health, according to scientists at WashU Medicine and the Veterans Affairs St. Louis Health Care System. But users may also face increased risks for pancreatitis and kidney conditions, among other illnesses.